ARCHIVES

Growth in Research Capacity Explains Increased Competition, NIH Director Tells NCAB.

This article is from The Cancer Letter archive.

Vol. 32 No. 23 | June 16, 2006

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

October 27, 2006

Low-Dose Aspirin Cuts Risk Of Colorectal Growths

April 26, 2002

Paraplatin Lengthened TTP In HER2+ Advanced Breast Ca

January 31, 2003

South African Investigator Bezwoda Admits Falsifying Data In High-Dose Chemo Study.

February 11, 2000

ODAC Recommends Ethyol, DaunoXome For FDA Approval

June 16, 1995

In Brief: NCAB To Ponder Organ Systems Program Fate, Cancer Centers Issues, Hear Surveillance Review

January 29, 1988